Table 3 Risk factors for recurrence in peritoneal cytology-positive, endometrial carcinoma stage IA patients (univariate and multivariate analysis).
Ā | N | HR (95% CI) | P-value | HR (95% CI) | P-value |
---|---|---|---|---|---|
Age (range) | |||||
ā<ā60 | 107 | 1 | 0.014 | 1 | 0.088 |
āā„ā60 | 28 | 3.96 (1.31ā11.9) | Ā | 2.86 (0.85ā9.56) | Ā |
BMI | |||||
ā<ā25 | 100 | 1 | 0.160 | Ā | Ā |
āā„ā25 | 35 | 2.28 (0.71ā7.20) | Ā | Ā | Ā |
Histology | |||||
Type I | 99 | 1 | 0.006 | 1 | 0.035 |
Type II | 36 | 4.76 (1.55ā14.5) | Ā | 3.56 (1.08ā11.6) | Ā |
Tumor size | |||||
āā„ā3Ā cm | 78 | 1 | 0.153 | Ā | Ā |
ā<ā3Ā cm | 57 | 0.44 (0.14ā1.35) | Ā | Ā | Ā |
Surgery | |||||
Laparoscopy | 17 | 1 | 0.152 | Ā | Ā |
Laparotomy | 118 | 0.38 (0.10ā1.43) | Ā | Ā | Ā |
Myometrial invasion | |||||
Without myometrial invasion | 43 | 1 | 0.54 | Ā | Ā |
With myometrial invasion | 92 | 0.71 (0.23ā2.16) | Ā | Ā | Ā |
LVSI | |||||
present | 27 | 1 | 0.669 | Ā | Ā |
absent | 108 | 0.71 (0.16ā3.25) | Ā | Ā | Ā |
Lymphadenectomy | |||||
Performed | 92 | 1 | 0.965 | Ā | Ā |
No performed | 43 | 0.96 (0.29ā3.18) | Ā | Ā | Ā |
With Adj chemotherapy | 58 | 1 | 0.781 | Ā | Ā |
Without Adj chemotherapy | 77 | 1.17 (0.39ā3.48) | Ā | Ā | Ā |